| Institution | PI Name | Title |
|---|
| Avanir Pharmaceuticals | Wolfgang Scholz | Development of Human Monoclonal Antibody for Treatment of Anthrax Exposure |
| Biota Scientific Management | Jane Ryan | Innovative Influenza Therapeutic and Prophylactic for Biodefense Applications |
| Burnham Institute for Medical Research | Maurizio Pellecchia | Development of an effective therapy against post-exposure Anthrax |
| Celera Diagnostics, LLC | Michael Zoccoli | The Development of a PCR-based Commercial Diagnostic Assay for Avian Influenza A |
| Colorado State University - Fort Collins | Ian Orme | Response Therapies for MDR-TB |
| Columbia University Health Sciences | Walter Ian Lipkin | Viral Arrays for Biodefense |
| Dor Biopharma, Inc. | Robert Newton Brey | Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin |
| Emergent Immunosolutions, Inc. | Gary Nabors | Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development |
| Genphar, Inc. | Jian-Yun Dong | Preclinical Evaluation of a Trivalent Marburg Vaccine |
| Global Vaccines, Inc. | Robert Johnston | A Novel Systemic and Mucosal Adjuvant for Biodefense |
| Henry M. Jackson Foundation for the Advancement of Military Medicine | Stephen Savarino | Development of an Adhesin-Toxoid Chimera Vaccine for Enterotoxigenic E. coli |
| Indevr, LLC | Kathy Rowlen | Advanced Microarray Technology for Pathogen Surveillance |
| Inviragen, LLC | Dan Stinchcomb | Preclinical development of a chimeric tetravalent dengue vaccine |
| Johns Hopkins University | T.C. Wu | Dev. of Optimized/Adjuvanted Smallpox DNA Vaccine (Gene Gun) |
| Macrogenics, Inc. | Jeffrey Nordstrom | Cocktail of Neutralizing MAbs for Smallpox Prevention |
| Massachusetts General Hospital | Emmett Schmidt | Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses |
| Medical College of Wisconsin | Kelly Henrickson | Rapid Point-of-Care Diagnostic for Bioterrorism 'A' agents and Pandemic Influenza |
| Microbiotix, Inc. | Terry Bowlin | Novel Small Molecule Inhibitors of Botulinum Neurotoxin A |
| Mount Sinai School of Medicine of NYU | Adolfo Garcia-Sastre | Live Attenuated Vaccines for Epidemic and Pandemic Flu |
| Napo Pharmaceuticals, Inc. | Barry Quart | Development of Crofelemer to Treat Vibrio cholerae |
| Nexbio, Inc. | Mang Yu | Development of Fludase as an Anti-Influenza Agent |
| Perlegen Sciences, Inc. | Renee Stokowski | Discovery of signature SNPs to distinguish Francisella strains by arrays |
| St. Jude Children's Research Hospital | Richard Webby | Therapeutic Monoclonal Antibodies to H5N1 Influenza |
| Scripps Research Institute | Erica Ollmann Saphire | Immunotherapeutics vs Ebola Sudan: Development, Structural & Functional Analysis |
| Scripps Research Institute | Luc Teyton | Using Lipids for Vaccination |
| State University of New York, Stony Brook | Peter Tonge | Chemotherapeutics Against Multi-Drug Resistant Tuberculosis |
| Symphogen A/S | Soren Bregenholt | Fully Human Recombinant Therapeutic Anti-Vaccinia Virus Polyclonal Antibody |
| University of Alabama at Birmingham | Christie Brouillette | Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia |
| University of California, Los Angeles | Benhur Lee | Small Molecule Inhibitors of Nipah and Hendra Virus Infection |
| University of Chicago | Olaf Schneewind | LcrV Plague Vaccine with Altered Immune Modulatory Properties |
| University of Illinois at Chicago | Zheng Chen | Immunotherapeutics and Vaccines Against Anthrax, Plague and Tularemia |
| University of Massachusetts Medical School, Worcester | Alan Rothman | Automated point-of-care PCR for hemorrhagic fever diagnosis |
| University of Minnesota, Twin Cities | Stephen Jameson | Developing Epicutaneous Vaccine Approaches for Protective Immunity |
| University of Pennsylvania | Paul Bates | Therapeutics Targeting Cathepsin-Activated Viral Entry |
| University of Pittsburgh at Pittsburgh | Zoltan Oltvai | Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria |
| University of Texas Medical Branch, Galveston | David Walker | Vaccine for Epidemic Typhus |
| University of Texas SW Medical Center, Dallas | Ellen Vitetta | Development of a lyophilized intradermal/intranasal ricin vaccine |
| University of Virginia, Charlottesville | Peter Ernst | Adenosine Receptor Agonists as an Immunotherapy for Biodefense |
| University of Virginia, Charlottesville | William Petri | Cooperative Research Partnership for an Amebic Colitis Vaccine |
| Universal Stabilization Technologies | Victor Bronshtein | Stable Micronized Vaccines Against Smallpox and Japanese Encephalitis |
| Wake Forest University Health Sciences | Stephen Mizel | Preclinical Development of Flagellin as a Mucosal Adjuvant in Biodefense Vaccines |
| Washington University | David Wang | A Diagnostic Microarray for hemorrhagic fever encephalitis viruses |
| Weill Medical College of Cornell University | Kendall Smith | New Strategies to Prevent Death from Influenza |
| Yale University | Erol Fikrig | Immunotherapeutics for Treatment of Flavivirus Infection |